Abstract:Controlled-release effervescent floating bilayer tablets reduce dosage frequency and improve patient compliance with enhanced therapeutic outcomes. Generally, two different tablets of clarithromycin and esomeprazole, respectively, are given for the treatment of Helicobacter pylori infection and it might be worth incorporating both in a single tablet. In the current study, controlled-release floating bilayer tablets of clarithromycin and esomeprazole (F1−F4) were developed with different rates of polymeric materials by a direct compression method. During the formulation, Fourier-transform infrared spectroscopy (FTIR) analysis was performed for possible interactions between drugs and excipients. No interactions between drugs and excipients were noted. Moreover, the bilayer tablets’ thickness, diameter, friability, hardness, weight variation, dissolution, and percent purity were found within the acceptable limits. The floating lag time and total floating time of all formulations were found to be < 25 s and 24 h, respectively. The release of both the clarithromycin and esomeprazole started at the same time from the controlled-release floating bilayer tablets by anomalous non-Fickian diffusion, and the polymeric materials extended the drug release rate up to 24 h. In the case of F1, the results approached ideal zero-order kinetics. The dissolution profiles of the tested and reference tablet formulations were compared, but no significant differences were observed. It can be concluded that such controlled-release effervescent floating bilayer tablets can be efficiently used in clinical practice to reduce dosage frequency and increase patient compliance with continuous drug release for 24 h, which ultimately might enhance therapeutic efficacy.

Evaluation of In-Vitro Dissolution and In-Vivo Absorption for Two Different Film-Coated Pellets of Clarithromycin.

Preparation and in Vitro Release Study of Sustained-release Coated Pellets Containing Clarithromycin

Comparison of External Dissolution among Four Kinds of Cefpodoxime Proxetil Tablets

Preparation of Clarithromycin-Containing Floating Pellets in Stomach

Pharmacokinetics and Bioequivalance of Clarithromycin Dispersed Tablet in Healthy Volunteers

Pharmacokinetic and Bioequivalence Evaluation of Two Cefprozil Dispersible Tablets in Healthy Chinese Volunteers

Pharmacokinetics and relative bioavalability of clarithromycin tablets

Pharmacokinetics and relative bioavailability of clarithromycin tablet in human

Pharmacokinetics and Bioequivalence of Clarithromycin Controlled-Release Tablets in Healthy Volunteers

Bioequivalence of Clarithromycin Soft Capsules in Healthy Chinese Volunteers

In Vitro Evaluation of Bioequiavailability of Felodipine Sustained-Release Tablets from Different Manufactures by Fiber-Optic Dissolution Test

Bioequivalence of Clarithromycin Dispersed Tablet in Health Volunteers

Studies on Preparation and in vitro Drug Release of Sodium Ferulate Double-layer Tablets

Pharmacokinetics and Bioequivalence of 2 Dosage Forms of Azithromycin Tablets in Healthy Volunteers

Bioequivalence Study of Erythromycin Cyclic 11,12-Carbonate Powder Suspension,capsule and Tablet

Bioequivalence Evaluation of Two Rabeprazole Enteric Coated Formulations in Healthy Chinese Volunteers

In vivo evaluation of a novel oral coating film tablet for the colon-specific drug delivery

Study on Formulation and Preparation Procedure of Erythromycin Ethylsuccinate Sustained-release Tablets and Their Influence on Drug Release

Preparation of Cefalexin Sustained-release Pellets and Investigation on Its Drug Release in Vitro

Preparation and Characterization of Controlled-Release Floating Bilayer Tablets of Esomeprazole and Clarithromycin

Formulation and in Vitro Characterization of Novel Sildenafil Citrate-Loaded Polyvinyl Alcohol-Polyethylene Glycol Graft Copolymer-Based Orally Dissolving Films.